Cancer Care for Immigrant Populations in the United States

Immigrants comprise a substantial and growing proportion of the US population, yet they face profound barriers to timely, affordable, and high-quality cancer care. These barriers are shaped not only by language, culture, and health literacy but also by federal and state policies that restrict insurance coverage, deter care-seeking, and heighten fear of immigration enforcement. Undocumented immigrants, in particular, remain largely excluded from Medicaid, Medicare, and other public benefits, while many lawfully present immigrants face eligibility restrictions, including the 5-year waiting period for Medicaid coverage. Although mechanisms such as Emergency Medicaid, state-funded Medicaid-equivalent programs, disease-specific safety-net programs, and Affordable Care Act waivers can help bridge gaps in access, these protections vary widely by state and remain vulnerable to policy change. Recent immigration enforcement actions and state-level requirements to collect citizenship or immigration status information in health care settings may further discourage patients from seeking care, including for cancer symptoms or treatment-related complications. For oncology professionals, these realities create urgent ethical, clinical, and practical responsibilities. Clinicians must understand how immigration and health policy affect access to care, seek institutional guidance on responding to immigration enforcement in clinical settings, and protect patient confidentiality whenever possible. At the same time, cancer programs must strengthen culturally competent care through professional interpretation, linguistically appropriate materials, community partnerships, culturally responsive care coordination, and workforce training. Ensuring equitable cancer care for immigrant populations requires both individual clinician awareness and systems-level commitment to access, trust, dignity, and high-quality care for all patients, regardless of national origin or immigration status.